LIVE Programme CEST time
SESSION VII – FRONTLINE INCORPORATION OF BiTEs and ADCs
Chairs: Mark Litzow (Rochester) & Anjali Advani (Cleveland)
18:20-18:25 Introduction Mark Litzow & Anjali Advani
18:25-18:45 Keynote: The MD Anderson Cancer Center Experience Hagop Kantarjian (Houston)
18:45-19:00 Adult ALL Trials Nicola Gökbuget (Frankfurt)
19:00-19:15 Childhood ALL Trials Lia Gore (Aurora)
19:15-19:30 Frontline Chemo-free Regimens in Ph+ ALL Sabina Chiaretti (Rome)
19:30-20:00 Panel discussion
Sunday, May 9th, 2021
13:00-14:00 4 Simultaneous Meet the Expert Sessions (Non- Clinical & Clinical)
- CAR T-cells : Practical Issues: Nicolas Boissel & Shannon Maude
- MRD Issues: Monika Brüggemann & Jan Zuna
- Allogenic SCT in ALL: Open issues: David Marks & Mark Litzow
- Optimal use if BiTEs: Nicola Gökbuget & Matthew Wieduwilt
SESSION VIII – T-CELL ALL and LYMPHOBLASTIC LYMPHOMA
Chairs: Anjali Advani (Cleveland) & David Marks (Bristol)
14:00-14:05 Introduction Anjali Advani & David Marks
14:05-14:25 Keynote: Management of T-LL Patients Dieter Hoelzer (Frankfurt)
14:25-14:40 Risk Factors in T-ALL Elizabeth Raetz (New York)
14:40-14:55 Should T-LL and T-ALLs be treated on the same protocols? Elisabeth Macintyre (Paris)
14:55-15:10 Novel Therapies for T-ALL/LL Anjali Advani (Cleveland)
BRIEF ORAL COMMUNICATION:
15:10-15:20 Pre-T Cell Receptor As a Therapeutic Target in T-Cell Acute Maria L Toribio (Madrid)
Lymphoblastic Leukemia
15:20-15:50 Panel discussion
15:50-16:00 Break
SESSION IX – Ph AND Ph-LIKE ALL
Chairs: Oliver Ottmann (Cardiff ) & Sabina Chiaretti (Rome)
16:00-16:05 Introduction Oliver Ottmann & Sabina Chiaretti
4